Cheng F W, Shefer S, Dayal B, Tint G S, Setoguchi T, Salen G, Mosbach E H
J Lipid Res. 1977 Jan;18(1):6-13.
This paper describes the conversion of 5beta-cholestane-3alpha,7alpha,12alpha,25-tetrol into 5beta-cholestane-3alpha,7alpha,12alpha,24beta,25-pentol by liver microsomes. A sensitive radioactive assay for measuring the formation of 5beta-cholestane-3alpha,7alpha,12alpha,24beta,25-pentol was developed. Optimal assay conditions for human and rat microsomal systems were established. A higher 24beta-hydroxylation activity was detected in rat than in human liver under the conditions employed. The hydroxylation of 5beta-cholestane-3alpha,7alpha,12alpha,25-tetrol by the rat liver microsomal fraction fortified with NADPH was stimulated about two-fold by administration of phenobarbital. Phenobarbital treatment also stimulated hydroxylations at C-23, C-24alpha, and C-26. Carbon monoxide markedly inhibited all side-chain hydroxylations. In contrast, side-chain hydroxylase activities were not affected in animals deprived of food for 48 hr. These results are consistent with a previously postulated cholic acid biosynthetic pathway involving 5beta-cholestane-3alpha,7alpha,12alpha,24beta,25-pentol as a key intermediate in man and in the rat.
本文描述了肝微粒体将5β-胆甾烷-3α,7α,12α,25-四醇转化为5β-胆甾烷-3α,7α,12α,24β,25-五醇的过程。开发了一种灵敏的放射性测定法来测量5β-胆甾烷-3α,7α,12α,24β,25-五醇的形成。确定了人和大鼠微粒体系统的最佳测定条件。在所采用的条件下,大鼠肝脏中检测到的24β-羟基化活性高于人肝脏。用NADPH强化的大鼠肝脏微粒体部分对5β-胆甾烷-3α,7α,12α,25-四醇的羟基化作用,经苯巴比妥给药后可刺激约两倍。苯巴比妥处理还刺激了C-23、C-24α和C-26位的羟基化。一氧化碳显著抑制所有侧链羟基化。相反,禁食48小时的动物的侧链羟化酶活性未受影响。这些结果与先前推测的胆酸生物合成途径一致,该途径涉及5β-胆甾烷-3α,7α,12α,24β,25-五醇作为人和大鼠的关键中间体。